Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Home Office:
To ask the Secretary of State for the Home Department, how many animals were authorised for use under project licences approved under the Animals (Scientific Procedures) Act 1986 between 1 January and 30 September 2026; how many of those animals were authorised for use in protocols with a maximum severity classification of severe by species; and how many were specially protected species, by species.
Answered by Sarah Jones - Minister of State (Home Office)
Project licences approved under the Animals (Scientific Procedures) Act 1986 between 1 January and 30 September 2026 authorised an estimated maximum of 3,866,547 animals over the lifetime of those licences. This is not a count of animals used during that nine-month period.
Of that total, an estimated maximum of 310,668 animals were authorised for use in protocols with a maximum severity classification of severe. The breakdown by species is set out below.
Species | Maximum number authorised with a prospective classification of severe |
Beagle | 500 |
Domestic fowl | 500 |
Guinea-pig | 528 |
Mice | 143,750 |
Other fish species | 145,230 |
Pig | 154 |
Rabbit | 460 |
Rat | 13,350 |
Rhesus monkey | 36 |
Syrian hamster | 480 |
Xenopus (laevis and tropicalis) | 5,180 |
Zebrafish | 500 |
Within the severe-protocol total, the specially protected species comprised an authorised maximum of 500 beagles and 36 rhesus macaques.
These figures represent authorised maxima, not the numbers of animals that will necessarily be used. The totals may include the same animal under more than one protocol where continued use or re-use is authorised, and should therefore not be interpreted as a count of distinct individual animals.
A protocol’s maximum severity classification does not mean that every animal used under it will experience that level of severity. Actual severity experienced by individual animals during regulated procedures is reported separately in the annual statistics.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department for Business, Innovation, Science and Trade:
To ask the Secretary of State for Business, Innovation, Science and Trade, how much of the funding announced alongside the Replacing Animals in Science strategy has been (a) allocated and (b) spent to date.
Answered by Chris McDonald - Minister of State (Department of Health and Social Care)
The Replacing Animals in Science Strategy was supported by £75 million to accelerate the development, validation and uptake of alternative methods. Funding allocated to date includes £30 million for the Medical Research Council-funded Preclinical Translational Models Hub, up to £2 million through Innovate UK to support human-relevant approaches to medicines testing (£316,268 spent to date), and £15.8 million for novel human in vitro disease models (£3.7 million spent to date across five projects). The Government is also in the process of allocating funding to establish the UK Centre for the Validation of Alternative Methods.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, what assessment he has made of whether DISP guidance is sufficient to ensure that Financial Ombudsman Service ombudsmen document and address Consumer Rights Act 2015 unfair contract terms arguments raised by complainants.
Answered by Lucy Rigby - Economic Secretary (HM Treasury)
The Financial Ombudsman Service (FOS) is an independent non-governmental body. The rules on how the FOS should handle complaints are set out in the Dispute Resolution (DISP) rules in the Financial Conduct Authority’s (FCA’s) Handbook.
How ombudsmen document their decisions is a matter for the FOS, acting in line with the legislative framework and the DISP rules. The current DISP guidance requires the FOS to take into account relevant law and regulations when considering what is fair and reasonable in all the circumstances of the case. This includes the Consumer Rights Act 2015 and its provisions on unfair contract terms, where relevant.
The Government has introduced legislation as part of the Financial Services and Markets Bill to reform the legal framework in which the FOS operates, to increase consistency and clarity of decision-making, helping people resolve disputes more quickly and with greater certainty. This includes placing an obligation on the FOS and FCA to publish joint thematic reports that will provide useful information and clarification on how the FOS will consider certain types of complaint.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the HM Treasury:
To ask the Chancellor of the Exchequer, if he will make representations to the Financial Ombudsman Service Board to require the Service to signpost complainants to the Independent Assessor and the applicable one-month time limit at the point of issuing a final decision letter.
Answered by Lucy Rigby - Economic Secretary (HM Treasury)
The Financial Ombudsman Service (FOS) is an independent, non-government body, and is best placed to respond to this question. The FOS will respond to the Honourable Member by letter, and a copy of the letter will be placed in the Library of the House of Commons.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department for Education:
To ask the Secretary of State for Education, what guidance her Department provides to schools on identifying and supporting pupils with Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS); and what assessment she has made of the potential educational impact of these conditions on affected children.
Answered by Georgia Gould - Minister of State (Education)
Schools are not responsible for making clinical judgements. Identifying and diagnosing medical conditions is the responsibility of the NHS. Schools should make referrals into NHS services and engage with the pupil’s family if they have a concern about a child’s health.
Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) are uncommon acute-onset conditions that can cause a sudden deterioration in emotional, cognitive and functional abilities. Symptoms such as abrupt obsessive-compulsive behaviours, tics, restricted eating, severe anxiety, sensory sensitivities and slowed processing can lead to the acute onset of special educational needs, with immediate impact on learning, wellbeing, participation and attendance.
Section 100 of the Children and Families Act 2014 places a duty on maintained schools, academies and pupil referral units to make arrangements for supporting pupils with medical conditions, which would include PANS and PANDAS. Schools should ensure that pupils with medical conditions have full access to education, including school trips and physical education. In doing so, schools must have regard to the department’s ‘Supporting pupils with medical conditions at school’ statutory guidance which is available at: https://www.gov.uk/government/publications/supporting-pupils-at-school-with-medical-conditions--3.
Under the proposed reforms, schools will be expected to identify special educational needs and disabilities through ongoing assessment of barriers to learning and participation, supported by the graduated approach, Individual Support Plans and access to multi-agency expertise.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what assessment his Department has made of the potential merits of the provision of interview questions in advance as a reasonable adjustment for jobseekers with learning disabilities and autism.
Answered by Andrew Western - Minister of State (Department for Work and Pensions)
DWP recognises that some disabled candidates, including people with learning disabilities and autistic people, may benefit from reasonable adjustments during recruitment and as such promotes practices that support fair and accessible recruitment, including the provision of interview questions in advance, the use of clear language and flexibility in assessment methods where appropriate. DWP's Learning Disabilities Project is also working with employers and specialist organisations to identify barriers to recruitment and develop practical guidance that supports more inclusive employment opportunities for people with learning disabilities.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what steps his Department is taking to encourage employers to offer paid work trials as an alternative to formal interviews for jobseekers with learning disabilities.
Answered by Diana Johnson - Minister of State (Department of Health and Social Care)
Education and skills are devolved matters, the response outlines the information for England only.
We are transforming the Apprenticeships Levy into a new Growth and Skills Levy in England, giving employers greater flexibility, creating more opportunities for young people, and directly supporting the Industrial Strategy.
In April 2026 we launched the first apprenticeship units focussing on priority sectors including artificial intelligence (AI), digital, construction and engineering. Apprenticeship units are short courses built from the knowledge and skills within existing employer-led occupational apprenticeship standards, ensuring high-quality, targeted training. They target immediate shortages in areas that will drive productivity and growth and will help employers upskill existing employees quickly and flexibly.
We have also reduced the apprenticeship minimum duration to 8 months, where this is appropriate for the role or the apprentice, as we know the previous 12-month minimum duration meant some employers and learners were prevented from accessing apprenticeships.
Additionally, we are also supporting more entry-level opportunities for young people, by introducing new foundation apprenticeships to give young people a route into careers in critical sectors, such as construction and health and social care.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the availability of early intervention and treatment pathways for children with Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS); and what steps he is taking to improve access to timely diagnosis and treatment.
Answered by Preet Kaur Gill
Paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are distressing conditions for children, young people, and their families, and we recognise the challenges that families face.
The Department acknowledges the importance of raising awareness of PANS/PANDAS to improve diagnosis. That is why we welcome the formation of the PANS PANDAS Steering Group which includes representatives from key royal colleges, specialist clinical bodies, and the national charity PANS PANDAS UK. The steering group has already taken action to improve awareness, understanding, and care.
Work is underway to develop the first United Kingdom clinical guidelines for PANS and PANDAS, led by a multidisciplinary group and supported by the Royal College of Paediatrics and Child Health. These guidelines are expected to be published in autumn 2026 and will support more consistent care across the system. Pending publication, the PANS PANDAS Steering Group recommends that clinicians be aware of existing international peer-reviewed guidelines, including the PANS research consortium treatment guidelines, published in 2017, and the clinical guidance for diagnosis and management of PANS in the Nordic Countries, published in 2021.
With the backing of NHS England, a dedicated PANS PANDAS research group is advancing efforts to strengthen the evidence base, including through a nationwide surveillance study, designed to identify the number of children and young people presenting to healthcare professionals with symptoms matching the diagnostic criteria for PANS and PANDAS.
In addition, a cross-sector group is developing practical guidance for local authorities to improve support for children and young people living with PANS and PANDAS. Publication is due later this year, ensuring more consistent access to appropriate educational and social care services.
More widely, healthcare professionals are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This includes taking account of new research and developments in guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high quality care to all patients.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of the level of clinical awareness and training on Paediatric Acute-onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS) among NHS professionals; and what steps he is taking to reduce variations in diagnosis and care.
Answered by Preet Kaur Gill
Paediatric acute-onset neuropsychiatric syndrome (PANS) and paediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS) are distressing conditions for children, young people, and their families, and we recognise the challenges that families face.
The Department acknowledges the importance of raising awareness of PANS/PANDAS to improve diagnosis. That is why we welcome the formation of the PANS PANDAS Steering Group which includes representatives from key royal colleges, specialist clinical bodies, and the national charity PANS PANDAS UK. The steering group has already taken action to improve awareness, understanding, and care.
Work is underway to develop the first United Kingdom clinical guidelines for PANS and PANDAS, led by a multidisciplinary group and supported by the Royal College of Paediatrics and Child Health. These guidelines are expected to be published in autumn 2026 and will support more consistent care across the system. Pending publication, the PANS PANDAS Steering Group recommends that clinicians be aware of existing international peer-reviewed guidelines, including the PANS research consortium treatment guidelines, published in 2017, and the clinical guidance for diagnosis and management of PANS in the Nordic Countries, published in 2021.
With the backing of NHS England, a dedicated PANS PANDAS research group is advancing efforts to strengthen the evidence base, including through a nationwide surveillance study, designed to identify the number of children and young people presenting to healthcare professionals with symptoms matching the diagnostic criteria for PANS and PANDAS.
In addition, a cross-sector group is developing practical guidance for local authorities to improve support for children and young people living with PANS and PANDAS. Publication is due later this year, ensuring more consistent access to appropriate educational and social care services.
More widely, healthcare professionals are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. This includes taking account of new research and developments in guidance, such as that produced by the National Institute for Health and Care Excellence, to ensure that they can continue to provide high quality care to all patients.
Asked by: Paul Kohler (Liberal Democrat - Wimbledon)
Question to the Department for Work and Pensions:
To ask the Secretary of State for Work and Pensions, what steps his Department is taking following the Keep Britain Working review to improve access to paid employment for people with learning disabilities.
Answered by Diana Johnson - Minister of State (Department of Health and Social Care)
Sir Charlie Mayfield’s independent Keep Britain Working Review, published on 5 November 2025, highlighted the scale of the problem of people falling out of work for reasons of ill-health and disability, and the vital role employers can play in addressing this. The Review identified structural challenges for disabled people, including people with learning disabilities, creating barriers to starting and staying in work, and proposed reforms to create healthier, more inclusive workplaces.
While the Keep Britain Working programme’s central aim is to improve workplace health and inclusion for those already in employment, improving workplace conditions, support and inclusion for people with learning disabilities and other disabled people will also help remove barriers to accessing paid employment and support more people to enter and sustain work.
Since publication of the Review, Keep Britian Working has engaged with 180 employers and providers, 11 regions, and worked directly with more than 250 organisations to explore how to create healthier and more inclusive workplaces. This work has included:
Alongside Keep Britain Working, the Government's Pathways to Work offer provides work, health and skills support for disabled people and people with health conditions, backed by £3.5bn of investment by the end of the decade. Pathways to Work includes Connect to Work, a voluntary and locally led Supported Employment programme for disabled people, those with health conditions and people facing complex barriers to work. It will deliver tailored support to around 300,000 people by the end of the decade across England and Wales.